연구실적

• A nationwide real-world study for evaluation of effectiveness and safety of T-DM1 in patients with HER2-positive metastatic breast cancer in Korea (KCSG BR19-15) Therapeutic Advances in Medical Oncology, 2024, v.16, 0
  SCIE Scopus dColl.
• Age- and ethnic-driven molecular and clinical disparity of East Asian breast cancers BMC Medicine, 2024, v.22 no.1, 422
  SCIE Scopus dColl.
• Evaluation of Group Genetic Counseling Sessions via a Metaverse-based Application Annals of Laboratory Medicine, 2024, v.44 no.1, 82-91
  SCIE Scopus KCI dColl.
• Genomic and transcriptomic profiles associated with response to eribulin and nivolumab combination in HER-2-negative metastatic breast cancer Cancer Immunology, Immunotherapy, 2024, v.73 no.10, 197
  SCIE Scopus dColl.
• Pemetrexed plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer (KCSG-BR15-17): A randomized, open-label, multicenter, phase II trial European Journal of Cancer, 2024, v.197, 113456
  SCIE Scopus dColl.
• A Phase II Trial of S-1 and Oxaliplatin in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane (KCSG-BR07-03) Cancer research and treatment, 2023, v.55 no.2, 523-530
  SCIE Scopus KCI dColl.
• Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16) European Journal of Cancer, 2023, v.195, 113386
  SCIE Scopus dColl.
• Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01) CANCERS, 2023, v.15 no.2, 471
  SCIE Scopus dColl.
• Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer Scientific Reports, 2023, v.13 no.1, 9928
  SCIE Scopus dColl.
• Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy Genes & Genomics, 2022, v.44 no.11, 1425-1435
  KCI dColl.
• Data collection framework for electronic medical record-based real-world data to evaluate the effectiveness and safety of cancer drugs: a nationwide real-world study of the Korean Cancer Study Group THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, v.14, 17588359221132600
  SCIE Scopus dColl.
• Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01) CANCER RESEARCH AND TREATMENT, 2022, v.54 no.1, 109-117
  SCIE Scopus KCI dColl.
• Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma Cancer Research and Treatment, 2022, v.54 no.2, 597-612
  SCIE Scopus KCI dColl.
• β‑catenin blockers enhance the effect of CDK4/6 inhibitors on stemness and proliferation suppression in endocrine‑resistant breast cancer cells Oncology reports, 2022, v.48 no.1
  SCIE Scopus dColl.
• Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12 CANCER RESEARCH AND TREATMENT, 2021, v.53 no.3, 671-677
  SCIE Scopus KCI dColl.
• Choosing Wisely: The Korean Perspective and Launch of the 'Right Decision in Cancer Care' Initiative CANCER RESEARCH AND TREATMENT, 2020, v.52 no.3, 655-660
  SCIE Scopus KCI dColl.
• Hyperprogressive disease and its clinical impact in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with immune-checkpoint inhibitors: Korean cancer study group HN 18–12 Journal of Cancer Research and Clinical Oncology, 2020, v. 146 no.12, 0
  SCIE Scopus dColl.
• Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10) CANCERS, 2020, v.12 no.11, 3265
  SCIE Scopus dColl.
• Peroxiredoxin 3 has important roles on arsenic trioxide induced apoptosis in human acute promyelocytic leukemia cell line via hyperoxidation of mitochondrial specific reactive oxygen species Molecules and Cells, 2020, v.43 no.9, 813-820
  SCIE Scopus KCI dColl.
• Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13-01) BMC CANCER, 2020, v.20 no.1, 813
  SCIE Scopus dColl.
• Human Epidermal Growth Factor Receptor 2-Subtype Invasive Ductal Carcinoma Recurring as Basal-Human Epidermal Growth Factor Receptor 2-Subtype Squamous Cell Carcinoma JOURNAL OF BREAST CANCER, 2019, v.22 no.3, 484-490
  SCIE Scopus KCI dColl.
• Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial LANCET ONCOLOGY, 2019, v.20 no.12, 1750-1759
  SCIE Scopus dColl.
• Spindle cell sarcoma mimicking supraclavicular lymph node metastasis of breast cancer American Journal of Case Reports, 2019, v.20, 194-197
  Scopus dColl.
• Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial CANCER DISCOVERY, 2019, v.9 no.10, 1388-1405
  SCIE Scopus dColl.
• Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG) GASTRIC CANCER, 2018, v.21 no.5, 819-830
  SCIE Scopus dColl.
• Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01) Cancer, 2017, v. 123 no.11
  SCIE Scopus dColl.
• The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cells ONCOLOGY LETTERS, 2017, v.14 no.1, 276-282
  SCIE Scopus dColl.
• A retrospective analysis for patients with HER2-positive gastric cancer who were treated with trastuzumab-based chemotherapy: In the perspectives of ethnicity and histology Cancer Research and Treatment, 2016, v.48 no.2, 553-560
  SCIE Scopus KCI dColl.
• Current Status and Challenges of Cancer Clinical Trials in Korea CANCER RESEARCH AND TREATMENT, 2016, v.48 no.1, 20-27
  SCIE KCI Scopus dColl.
• Germ Cell Tumor Targeting Chemotherapy in Gastric Adenocarcinoma with an Endodermal Sinus Tumor Component: A Case Report Chemotherapy, 2016, v.62 no.1, 54-57
  SCIE Scopus dColl.
• Inhibition of beta-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line PLOS ONE, 2016, v.11 no.5
  SCIE Scopus dColl.
• MITOCHONDRIAL SPECIFIC ROS HYPEROXIDATION VIA PEROXIREDOXIN III HAS IMPORTANT ROLES ON ARSENIC TRIOXIDE INDUCED APOPTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA HAEMATOLOGICA, 2016, v.101, 672-672
  SCIE Scopus dColl.
• Manipulation of beta-catenin pathway to overcome endocrine resistance in breast cancer. JOURNAL OF CLINICAL ONCOLOGY, 2015, v.33 no.15
  SCIE Scopus dColl.
• The efficacy of low-dose transdermal fentanyl in opioid-naïve cancer patients with moderate-to-severe pain Korean Journal of Internal Medicine, 2015, v.30 no.1, 88-95
  SCIE KCI dColl.
• Meeting highlights: The first Korean breast cancer treatment consensus conference Journal of Breast Cancer, 2014, v.17 no.4, 308-313
  SCIE KCI Scopus dColl.
• Topoisomerase II alpha and microtubule-associated protein-tau as a predictive marker in axillary lymph node positive breast cancer TUMORI, 2014, v.100 no.1, 80-86
  SCIE Scopus dColl.
• Ascorbic acid insufficiency induces the severe defect on bone formation via the down-regulation of osteocalcin production Anatomy and Cell Biology, 2013, v.46 no.4, 254-261
  KCI dColl.

학력